to be consistent with histology slides obtained from the primary hospital. The patient was informed of the misdiagnosis. The patient refused any further surgery (hip disarticulation or endoprosthetic replacement of the whole femur) based on symptom improvement, ability to mobilise independently without any walking aids and his age. To our knowledge, this is the oldest case in English literature of a patient with adamantinoma of the femur. He was followed up in our clinic for 36 months with serial radiographs and was free of disease at the last follow-up. Written informed consent was obtained from the patient. Some case reports of femoral adamantinoma exist, one of which describes a 60-year-old lady (2) and in another paper a 72-yearold patient (3). Surgery is the mainstay treatment and involves en bloc resection with wide margins and reconstruction (4). There is no role for curettage of the lesion, as this leads to marginal excision and inadequate margins. In our case, the patient was mismanaged because of the wrong reporting of histology. Biopsy was not conducted prior to the 'metastatectomy and cementation' as adamantinoma was not at all suspected in a patient of this age. This case report describes the difficulty in diagnosing this rare lesion, which is particularly rare in elderly patients. It reminds us of the fact that one should never drift from the basic oncological principles in the management of a suspicious lesion. All these patients should be treated at a specialist unit with multidisciplinary expertise to avoid surprises. All previous investigations should be reviewed prior to planning and offering any further treatment.
